Intellectual Property India Publishes Patent Application for Combination Therapy Using Psma-Targeted Radiopharmaceuticals And An Inhibitor Of Pi3k, Akt, And/Or Mtor

MUMBAI, India, Aug. 17 -- Intellectual Property India has published a patent application (202617080158 A) filed by Swiss Rockets AG on June 29, 2026, for Combination Therapy Using Psma-Targeted Radiopharmaceuticals And An Inhibitor Of Pi3k, Akt, And/Or Mtor.

Inventors include Cmiljanovic, Vladimir; and Gracheva, Nadezda.

The application for the patent was published on August 14, 2026, under issue no. 33/2026.

Abstract: The disclosure relates to kits of parts and compositions comprising a PSMA-targeted radiopharmaceutical, e.g., PSMA I&T, and an inhibitor of PI3K, AKT, and/or mTOR, e.g., bimiralisib, for the treatment of a cancer, preferably a prostate cancer.

Disclaimer: Curated by HT Syndication.